4//SEC Filing
Hecht Beth 4
Accession 0001867096-25-000011
CIK 0001867096other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:40 PM ET
Size
5.1 KB
Accession
0001867096-25-000011
Insider Transaction Report
Form 4
Hecht Beth
See Remarks
Transactions
- Tax Payment
Common Stock
2025-01-03$3.61/sh−32,039$115,661→ 1,352,794 total
Footnotes (2)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of Restricted Stock Units vested as of January 3, 2025.
- [F2]Includes 4,031 shares acquired on December 31, 2024 under the Xeris Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan, as amended.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001652410
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:40 PM ET
- Size
- 5.1 KB